Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 2
2004 2
2005 1
2006 4
2007 2
2008 3
2009 3
2011 1
2012 1
2013 1
2014 5
2015 2
2016 1
2017 5
2018 2
2019 3
2020 3
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.
Chung EY, Palmer SC, Saglimbene VM, Craig JC, Tonelli M, Strippoli GF. Chung EY, et al. Cochrane Database Syst Rev. 2023 Feb 13;2(2):CD010590. doi: 10.1002/14651858.CD010590.pub3. Cochrane Database Syst Rev. 2023. PMID: 36791280 Free PMC article. Review.
This is an update of a Cochrane review first published in 2014. OBJECTIVES: To compare the efficacy and safety of ESAs (epoetin alfa, epoetin beta, darbepoetin alfa, methoxy polyethylene glycol-epoetin beta, and biosimilar ESAs against each othe …
This is an update of a Cochrane review first published in 2014. OBJECTIVES: To compare the efficacy and safety of ESAs (epoetin al …
Mortality risk of darbepoetin alfa versus epoetin alfa in patients with CKD: systematic review and meta-analysis.
Wilhelm-Leen ER, Winkelmayer WC. Wilhelm-Leen ER, et al. Am J Kidney Dis. 2015 Jul;66(1):69-74. doi: 10.1053/j.ajkd.2014.12.012. Epub 2015 Jan 28. Am J Kidney Dis. 2015. PMID: 25636816 Free PMC article. Review.
BACKGROUND: Epoetin alfa (EPO) and darbepoetin alfa (DPO) are erythropoiesis-stimulating agents that are widely and interchangeably used for the treatment of anemia in patients with advanced chronic kidney disease and end-stage renal disease. ...
BACKGROUND: Epoetin alfa (EPO) and darbepoetin alfa (DPO) are erythropoiesis-stimulating agents that are widely and int …
The relative dosing of epoetin alfa and darbepoetin alfa in chronic kidney disease.
Cremieux PY, Van Audenrode M, Lefebvre P. Cremieux PY, et al. Curr Med Res Opin. 2006 Dec;22(12):2329-36. doi: 10.1185/030079906X154024. Curr Med Res Opin. 2006. PMID: 17257447 Review.
RESULTS: A total of 21 studies involving 16 378 patients exposed to epoetin alfa or darbepoetin alfa in CKD were identified. Univariate analysis of the dose ratios indicated a mean dose ratio of 217:1 (IU of epoetin alfa:mug of darbepoetin al …
RESULTS: A total of 21 studies involving 16 378 patients exposed to epoetin alfa or darbepoetin alfa in CKD were identi …
Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: a systematic review of the literature.
Ross SD, Allen IE, Henry DH, Seaman C, Sercus B, Goodnough LT. Ross SD, et al. Clin Ther. 2006 Jun;28(6):801-31. doi: 10.1016/j.clinthera.2006.06.003. Clin Ther. 2006. PMID: 16860166 Review.
OBJECTIVES: The aims of this work were to provide up-to-date assessments of the clinical efficacy and effectiveness (ie, transfusions and quality-of-life [QoL] benefits) and safety (ie, risk of venous thromboembolism [VTE] and all-cause or treatment-associated death) of epoeti …
OBJECTIVES: The aims of this work were to provide up-to-date assessments of the clinical efficacy and effectiveness (ie, transfusions and qu …
A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.
Wilson J, Yao GL, Raftery J, Bohlius J, Brunskill S, Sandercock J, Bayliss S, Moss P, Stanworth S, Hyde C. Wilson J, et al. Health Technol Assess. 2007 Apr;11(13):1-202, iii-iv. doi: 10.3310/hta11130. Health Technol Assess. 2007. PMID: 17408534 Free article. Review.
OBJECTIVES: To assess the effectiveness and cost-effectiveness of epoetin alpha, epoetin beta and darbepoetin alpha (referred to collectively in this report as epo) in anaemia associated with cancer, especially that attributable to cancer treatment. ...
OBJECTIVES: To assess the effectiveness and cost-effectiveness of epoetin alpha, epoetin beta and darbepoetin alpha (referred …
Systematic Review of Erythropoietin (EPO) for Neuroprotection in Human Studies.
Hemani S, Lane O, Agarwal S, Yu SP, Woodbury A. Hemani S, et al. Neurochem Res. 2021 Apr;46(4):732-739. doi: 10.1007/s11064-021-03242-z. Epub 2021 Feb 1. Neurochem Res. 2021. PMID: 33521906 Review.
The PubMed search resulted in the following search strategy: ("erythropoietin" [MeSH Terms] OR "erythropoietin" [All Fields] OR "epoetin alfa" [MeSH Terms] OR ("epoetin" [All Fields] AND "alfa" [All Fields]) OR "epoetin alfa" [All Fields] …
The PubMed search resulted in the following search strategy: ("erythropoietin" [MeSH Terms] OR "erythropoietin" [All Fields] OR "epoetin …
Spine Surgery and Blood Loss: Systematic Review of Clinical Evidence.
Willner D, Spennati V, Stohl S, Tosti G, Aloisio S, Bilotta F. Willner D, et al. Anesth Analg. 2016 Nov;123(5):1307-1315. doi: 10.1213/ANE.0000000000001485. Anesth Analg. 2016. PMID: 27749350 Review.
Selected articles were categorized into 3 subchapters: (1) drugs active on coagulation (12 studies): tranexamic acid, aminocaproic acid, aprotinin, and recombinant activated factor VII; (2) drugs not active on coagulation (5 studies): ketorolac, epoetin alfa, magnes …
Selected articles were categorized into 3 subchapters: (1) drugs active on coagulation (12 studies): tranexamic acid, aminocaproic acid, apr …
Methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa for anemia in non-dialysis-dependent CKD: a systematic review.
Alsalimy N, Awaisu A. Alsalimy N, et al. Int J Clin Pharm. 2014 Dec;36(6):1115-25. doi: 10.1007/s11096-014-0023-x. Epub 2014 Oct 7. Int J Clin Pharm. 2014. PMID: 25288147 Review.
AIM OF THE REVIEW: To evaluate the efficacy and tolerability of MPG-EPO compared with other erythropoiesis stimulating agents (in particular darbepoetin alfa) for the treatment of anemia in non-dialysis-dependent CKD patients. ...The proportion of patients requiring RBC tr …
AIM OF THE REVIEW: To evaluate the efficacy and tolerability of MPG-EPO compared with other erythropoiesis stimulating agents (in particular …
Systematic review of pharmacologic and non-pharmacologic interventions to manage cognitive alterations after chemotherapy for breast cancer.
Chan RJ, McCarthy AL, Devenish J, Sullivan KA, Chan A. Chan RJ, et al. Eur J Cancer. 2015 Mar;51(4):437-450. doi: 10.1016/j.ejca.2014.12.017. Epub 2015 Jan 23. Eur J Cancer. 2015. PMID: 25623439 Free article. Review.
Pharmacologic interventions included psychostimulants (n=4), epoetin alfa (n=1) and Ginkgo biloba (n=1). Non-pharmacologic interventions were cognitive training (n=5) and physical activity (n=2). Pharmacologic agents were ineffective except for self-reported cogniti …
Pharmacologic interventions included psychostimulants (n=4), epoetin alfa (n=1) and Ginkgo biloba (n=1). Non-pharmacologic int …
43 results